The role of N-linked glycosylation in the biological activity of the measles virus (MV) fusion (F) protein was analyzed by expressing glycosylation mutants with recombinant vaccinia virus vectors. There are three potential N-linked glycosylation sites located on the F2 subunit polypeptide of MV F, at asparagine residues 29, 61, and 67. Each of the three potential glycosylation sites was mutated separately as well as in combination with the other sites. Expression of mutant proteins in mammalian cells showed that all three sites are used for the addition of N-linked oligosaccharides. Cell surface expression of mutant proteins was reduced by 50% relative to the wild-type level when glycosylation at either Asn-29 or Asn-61 was abolished. Despite the similar levels of cell surface expression, the Asn-29 and Asn-61 mutant proteins had different biological activities. While the Asn-61 mutant was capable of inducing syncytium formation, the Asn-29 mutant protein did not exhibit any significant cell fusion activity. Inactivation of the Asn-67 glycosylation site also reduced cell surface transport of mutant protein but had little effect on its ability to cause cell fusion. However, when the Asn-67 mutation was combined with mutations at either of the other two sites, cleavage-dependent activation, cell surface expression, and cell fusion activity were completely abolished. Our data show that the loss of N-linked oligosaccharides markedly impaired the proteolytic cleavage, stability, and biological activity of the MV F protein. The oligosaccharide side chains in MV F are thus essential for optimum conformation of the extracellular F2 subunit that is presumed to bind cellular membranes.
Measles virus (MV) is an enveloped RNA virus which contains a linear single-stranded RNA genome of negative polarity. The MV particle contains two integral surface glycoproteins, the hemagglutinin (HA) and fusion (F) proteins, in addition to a nonglycosylated matrix (M) protein that forms the inner layer of the envelope. The MV ribonucleoprotein core contains the genomic RNA and three associated proteins: the nucleocapsid (NP), a phosphoprotein (P), and a presumed RNA polymerase large protein (L) (25) .
The predicted primary structure of the MV F protein is composed of 550 amino acids with a calculated mass of 59,510 Da (32) . The MV F protein is required for virus penetration into the host cell (6) . This is accomplished through a process of membrane fusion between the virus envelope and the host cell membrane. When the full-length F protein cDNA was inserted into the DNA genome of human adenovirus type 5, high levels of biologically active MV F protein expression were reported (3) . Other virus systems have also been used to direct the synthesis of biologically active F protein in insect and mammalian cells (40, 43) .
In MV-infected cells, the F protein is synthesized as an inactive precursor, F0, which is subsequently cleaved by host proteolytic enzymes to generate a nonglycosylated F1 and a glycosylated F2 polypeptide subunit linked together by a disulfide bond (12, 35) . Cleavage of the F0 precursor generates a new hydrophobic amino terminus on the F1 polypeptide. F1 contains the carboxy-terminal region of the precursor and is anchored in the viral membrane, while the F2 subunit contains the original amino terminus minus the signal peptide (35) . The amino-terminal hydrophobic region of F1 is highly conserved among paramyxoviruses and has considerable homology with the human immunodeficiency virus type 1 (HIV-1) gp4l amino terminus (5) . This region of the F, polypeptide is believed to mediate the membrane fusion activity of paramyxoviruses (36) . Previous work with the paramyxovirus simian virus 5 F protein has indicated that the hydrophobic amino terminus of F1 is capable of interacting directly with cellular membranes (29) .
Glycosylation of viral membrane proteins has been shown to influence stability and intracellular transport (reviewed in reference 9). Inhibition of N-linked glycosylation by using tunicamycin has been shown to retard the transport of many but not all glycoproteins (26) . There have been many indications that carbohydrate side chains may function to protect against proteolytic degradation, promote correct folding, and improve the solubility of glycoproteins (26) . Evidence for a role for glycosylation in proteolytic cleavage of viral precursor glycoproteins has been reported. Inhibition of N-linked glycosylation inhibited the processing of Sindbis virus envelope protein E2 (20) and the Newcastle Disease virus F glycoprotein (23) , suggesting a carbohydrate requirement for specific proteolytic cleavage. Others have found that site-specific glycosylation can influence cleavage of the CK/Penn strain of avian influenza virus hemagglutinin (7) . Studies on the HIV-1 enve- The G3 mutant was generated by using the four PCR primers indicated.
Mutated bases are underlined.
lope glycoprotein gp160 have shown that its cleavage into a biologically active protein is dependent on the addition of N-linked oligosaccharides (8) .
Although much is known about the biological activities of paramyxovirus F proteins, the structural features involved in cleavage activation and/or membrane fusion activity are still not well understood. The importance of N-linked glycosylation in the fusion activity of the MV F protein has been suggested previously (3) . Proteolytic cleavage of the F, precursor protein has been shown to be completely abolished in the presence of tunicamycin. Recent studies on the HIV-1 envelope protein indicated that the switch from a non-syncytium-inducing to a syncytium-inducing phenotype was associated with the length and number of potential N-linked glycosylation sites in the V2 hypervariable loop (13) .
We have now examined the role of glycosylation in the processing, intracellular transport, and fusion activity of the MV F protein. Our Oligonucleotide-directed mutagenesis and construction of recombinant vaccinia viruses. Recombinant plasmids containing various modifications of the MV F protein were constructed by standard cloning techniques as reported previously (2, 3) . Plasmid pJV-NheI, which contains the full-length coding region of the wild-type MV F protein, has been described previously (43) . The NheI-BamHI DNA fragment of pJV-NheI represents most of the MV F coding region, including the ATG initiation codon and the F, subunit sequences, which contain all the potential N-linked glycosylation sites. The NheI-BarnHI cDNA insert was purified and subcloned into the BamnHI site of the double-stranded replicative form of pBluescript SK(+/-) phagemid (20, 38) . The resulting plasmid was designated SK/MVF.
Oligonucleotide-directed mutagenesis was performed as described by Kunkel et al. (17) . Single-stranded DNA prepared from SK/MVF was used as the template for in vitro mutagenesis. Four oligonucleotides were synthesized by the Biotechnology Research Institute Facility, Montreal, with a DNA synthesizer. The oligonucleotides (Table 1) were designed so that the Asn-encoding codons were mutated to Gln-encoding codons. Mutants were verified by DNA sequencing by the dideoxynucleotide chain termination method (33) . Elimination of all three glycosylation sites was achieved by using FG1 and FG23 oligonucleotides as primers on the single-stranded SK/ MVF template. The G3 mutation was constructed with a PCR fragment. The fragment was generated by priming pRW908 with RW441 and RW442. A second PCR with pRW908 as the template was primed with RW443 and RW444. The two PCR products were pooled, primed for a final PCR with RW441 and RW444, and digested with HpaI and Nael. The resulting 352-bp HpaI-NaeI DNA fragments of each mutant were purified and used to replace the equivalent fragment in pRW908. Plasmid pRW908, which contains the vaccinia virus KIL gene and directs insertion to the ATI locus, also contains the wild-type MV F gene linked to the vaccinia virus H6 promoter. Plasmids generated from pRW908 containing glycosylation mutations were used for in vivo recombination and selected by using a host range selection system similar to that described by Perkus et al. (30) . In this case, the highly attenuated host range-restricted vaccinia virus strain NYVAC (38) (43) . Gel-purified F, was used to immunize rabbits for antibody production as described previously (31) . Anti (Amersham) at 50 p.Ci/ml in methionine-free DMEM (Flow Laboratories) containing 10% FBS (Hyclone). Cell lysates were prepared and analyzed as previously described (1, 2) . Briefly, cellular proteins were extracted in RIPA buffer (0.1% sodium dodecyl sulfate [SDS], 1% Triton X-100, 1% sodium deoxycholate, 150 mM NaCl, 0.5 mg of aprotinin per ml, 10 mM Tris-HCl [pH 7.4]). Lysed cells were microfuged for 30 s, and the supernatants were used for immunoprecipitation with the anti-MV F polyclonal antibodies described in the previous section. Antigen-antibody complexes were precipitated with protein A-Sepharose beads (Pharmacia) and washed three times in RIPA buffer. Precipitated proteins were removed from protein A-Sepharose beads by boiling in lysis buffer and analyzed by SDS-polyacrylamide gel electrophoresis under reducing conditions. Tunicamycin treatment and endo H digestion. Infected CV1 cells labelled with [35S]methionine were treated with tunicamycin by previously described methods (2) . The drug (1-mg/ml stock solution in dimethyl sulfoxide) was added 2 h before metabolic labelling and was maintained at a final concentration of 20 ,g/ml throughout the labelling period. Endoglycosidase H (endo H) digestion was performed on immunoprecipitated glycosylated MV F mutant proteins. Confluent monolayers of CV1 cells were grown in 60-mm dishes and infected, in duplicate, at an MOI of 10 PFU/cell. At 4 h p.i., infected cells were washed with PBS and pulse labelled for 30 min with 200 ,uCi of [35S]methionine (Amersham) per ml. One set of infected cells was washed with PBS, lysed in RIPA buffer, and immunoprecipitated as described in the previous section. This was considered the time zero of the chase period. The other set of infected cells was washed with PBS before addition of fresh medium containing nonradioactive methionine, and incubation was continued for 4 h. After the chase period, cells were lysed and immunoprecipitated. Antigen-antibody complexes were eluted from protein A-Sepharose beads by boiling for 5 min in 50 mM Tris-HCl (pH 7.0) containing 0.5% SDS. Supernatants were removed, and an equal volume of 0.1 M sodium acetate (pH 5.0) containing 1 mM phenylmethylsulfonyl fluoride and 5 mU of endo H (Boehringer Mannheim GmbH) was added. Protein samples were digested with endo H for 20 h at 37°C. After digestion, gel sample buffer was added, and samples were analyzed on SDS-12% polyacrylamide gels by the method of Laemmli (18 Fig. 5 were calculated by the cumulative subtraction method described by Overton (27) .
Cell fusion activity and hemolysis assays. To inhibit the observed low levels of cell fusion activity caused by vaccinia virus, subconfluent monolayers of NCI-H460 cells were treated with 100 ,ug of rifampin per ml (16) (Sigma) and then infected with the recombinant vaccinia viruses. Cells were either infected at an MOI of 20 PFU/cell with F recombinants alone or coinfected with both HA and F recombinants (each at an MOI of 10 PFU/cell) for 20 h. Syncytium formation was monitored under a phase-contrast microscope (Leitz), and cells were photographed with Kodak Technical Pan Film at a magnification of x 320.
For the hemolysis assays, African green monkey erythrocytes (Connaught Laboratories, Toronto, Canada) were washed three times with PBS and resuspended in PBS to give a 10% suspension. Aliquots of 1.5 ml of the erythrocyte suspension were overlaid on infected NCI-H460 cells and incubated at 37°C for 24 h. The erythrocyte suspension was removed from each infected-cell monolayer, and erythrocytes were sedimented by low-speed centrifugation. Hemolysis was quantitated by using a spectrophotometer at a wavelength of 540 nm.
RESULTS
Design of N-linked glycosylation mutants and construction of recombinant vaccinia viruses. There are four potential N-linked glycosylation sites (Asn-X-Ser/Thr) in the predicted amino acid sequence of the MV fusion protein (32) . Since the first site at asparagine 6 (Asn-Val-Ser) lies within the signal peptide sequence which is cleaved during protein processing, it does not contribute directly to glycosylation of the final F protein product. The second site is at asparagine 29 (Asn-LeuSer), the third is at asparagine 61 (Asn-Ile-Thr), and the fourth is at asparagine 67 (Asn-Cys-Thr). These potential carbohydrate attachment sites are all located on the F2 subunit. The larger F, subunit is a nonglycosylated polypeptide. This is a unique characteristic for MV F since other members of the paramyxovirus family are known to have potential glycosylation sites on both the F1 and F2 subunits (4, 10, 28) .
The addition of N-linked oligosaccharides was prevented by changing the first codon in the consensus sequence (Asn-XThr/Ser) from asparagine to glutamine in all glycosylation mutants that were constructed. This change is fairly conservative, since it probably induces the least conformational change in the protein molecule. The oligonucleotides used to mutate the codons for asparagine residues 29, 61, and 67 are shown in Table 1 . The mutants in which consensus sequences were altered singly were designated Gl, G2, and G3. The positions of these N-linked sites are numbered sequentially from the amino terminus of MV F (Fig. 1) . The double mutant is referred to as G23, and the triple mutant is referred to as G123 (Fig. 1) .
The oligonucleotides were used as primers to synthesize (Fig. 1) . The recombinant viruses were (Fig. 2, FO) .
The difference in electrophoretic mobility between wild-type and mutant polypeptides was more obvious in the F2 band. As shown in Fig. 2 It was assumed that the fainter band below F2 observed in the immunoprecipitates shown in Fig. 2 and 3 is another form of F2 that probably resulted from differences in carbohydrate trimming and modification. We have previously observed FO protein as a doublet band in 293 cells infected with either MV or an MV F-adenovirus recombinant (3) . The multiple F( bands observed in Fig. 2 and 3 may indicate a possible difference in the extent of glycosylation. Alternatively, these bands could represent other forms of FO that resulted from selective usage of the glycosylation sites or different protein processing. The protein species below F1 (Fig. 3) , which was immunoprecipitated only with FELC antiserum, is a crossreactive protein that is not related to F since it also appeared in the control-virus-infected cells. The higher-molecularweight protein bands observed in Fig. 3 may be attributed to incomplete denaturation of the protein samples, since they were not consistently seen in other experiments.
Intracellular stability and posttranslational modifications of F proteins. The intracellular stability and cleavage of mutant proteins were examined by pulse-chase experiments followed by densitometric scanning analysis of processed proteins (Fig.  4) . After a 4-h chase period, densitometric scanning of F2 bands indicated that only 20 to 30% of the oligosaccharides on any of the proteins were resistant to endo H digestion (Fig. 4) .
These results were further confirmed by scanning the F( bands before and after endo H treatment. No endo H resistance was observed for either the double mutant G23 (data not shown) or the triple mutant G123 (Fig. 4) . Acquisition of endo H resistance indicates that the glycoprotein has reached the medial Golgi (14, 26) .
It is evident that elimination of all N-linked oligosaccharide addition sites impaired intracellular transport of the G23 and G123 mutant proteins to the Golgi. Based on the rate at which the GI, G2, and G3 mutant proteins acquired endo H resistance, it was evident that removal of any single N-linked glycosylation site did not seem to block intracellular transport to the Golgi. All single-site mutant proteins were relatively stable after a 4-h chase period. The relative amounts of wild-type and single-site mutant F polypeptides remaining after the chase period were determined to be between 75 and 80%. In contrast, double or triple mutant proteins showed a decrease in their rate of accumulation over time, with only 40 to 50% of G123 remaining at the end of the chase (Fig. 4) .
The results in Fig. 4 were also used to determine the efficiency of cleavage of precursor (F0) proteins. (Fig. 4) . No cleavage products were observed for either the G23 or G123 mutant polypeptide (Fig. 2, 3, and 4) . single-site mutants expressed lower levels (compared with wild-type F) of mutant F proteins at the cell surface. The levels of the G3 mutant protein detected at the cell surface were only 10% lower than wild-type levels, while the GI and G2 surface levels were reduced to 50% of the wild-type levels (Fig. SB) . Significant cell surface expression could not be detected with either G23-or G123-encoded proteins (Fig. SB) . These experiments were repeated four times for each cell line, and the results were reproducible without significant variation.
Analysis of membrane fusion activity of expressed F proteins. The cell line NCI-H460 was used to monitor the cell fusion activity of wild-type and mutant F proteins. Infection of this cell line with recombinant vaccinia viruses did not result in the severe cytopathic effect typical of vaccinia virus infections. This made it possible to observe the fusogenic activities of wild-type and mutant F proteins. Subconfluent monolayers of NCI-H460 cells were treated with rifampin before infection with the recombinant viruses. Rifampin was used to inhibit the low cell fusion activity caused by vaccinia virus (16 To confirm these results and obtain a more accurate measure of fusion activity, a hemolysis assay was used (3, 43) . Since MV HA was found to enhance syncytium formation, HAvaccinia virus and F recombinants were used to coinfect NCI-H460 cells. The results ( expected to be used, since it contains the only cysteine residue found in the F2 subunit (32) . This cysteine residue must be involved in the formation of the disulfide bond that holds the two subunits together. It seems that two adjacent amino acids are involved in two different interactions. Asn-67 in glycosylation and Cys-68 in disulfide bond formation. This is another unique structural feature of the MV F protein that has not been described for other paramyxovirus F proteins.
It was demonstrated that single-site mutants showed different biological characteristics. These differences were dependent on the position of the inactivated glycosylation site.
Similar findings have been reported previously for the simian virus 5 HN glycoprotein (24) . The glycosylation site most proximal to the amino terminus (Gl) seemed to be more important than the other two sites (G2 and G3). Although the Gl and G2 mutant proteins were similarly affected in cleavage efficiency and transport to cell surface, the Gl protein was incapable of inducing cell-cell fusion and hemolysis ( Fig. 6 and Table 2 ), whereas G2 did exhibit such biological activity. The predicted secondary structure of the MV F protein (32) revealed that the F2 polypeptide is probably involved in the formation of a globular head that serves in attachment of the It was also demonstrated that transport to the Golgi and the plasma membrane was affected but not abolished by inactivation of any one of the N-linked glycosylation sites. Similar studies on influenza virus HA indicated that the loss of any single N-linked site is tolerated but elimination of three or more sites partially or completely blocked transport to the cell surface (11) . Other studies with N-linked glycosylation mutants of the vesicular stomatitis virus G protein have demonstrated that only one of the two normal sites is sufficient for cell surface expression (21) . It seems that oligosaccharides at the Gl and/or G2 sites may contribute more significantly to cell surface transport than those at the G3 site. A direct role for N-linked glycosylation in transport of vesicular stomatitis virus G protein to the cell surface has been suggested (14) . However, the results presented here imply that the loss of carbohydrate groups alters the conformation of MV F, which may then affect transport to the cell surface. The pulse-chase experiments show that elimination of either the Gl or the G2 site resulted in accumulation of the uncleaved form of protein (FO 
